Company CVAbout Haleos Labs Limited 
Haleos Labs Limited
Micro Cap
Pharmaceuticals & Biotechnology
SMS Lifesciences India Limited was incorporated originally as "Potluri Real Estate Private Limited" on May 31, 2006. The Company's name was changed to "Potluri Packaging Industries Private Limited" on 6 November, 2013 and again changed to "SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector. The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.
Company Coordinates
Company Details
Plot No 19-III Road No 71, Opp Bharatiya Vidya Bhavan PSc Hyderabad Telangana : 500096
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 3.02 Cr
Number of Shares
30.23 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
17-Aug-2017
30.23
3.02
3023287
10
Allotment of Equity To Others
17-Aug-2017
30.23
3.02
3023287
10
Allotment of Equity To Others
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 1 FIIs (0.03%)
Promoter with highest holding
Annapurna Talluri (24.56%)
Highest Public shareholder
Harita Projects Private (1.57%)
Individual Investors Holdings
25.55%
Board of Directors
Management
Designation
Remuneration
T V V S N Murthy
Managing Director
2.01 cr
P Sarath Kumar
Independent Director
6.0 lacs
Trupti Ranjan Mohanty
Company Sec. & Compli. Officer
0
Talluri Venkata Praveen
Executive Director
72.0 lacs
Sudeepthi Gopin eedi
Whole-time Director
19.35 lacs
Mannam Malakondaiah
Independent Director
2.15 lacs
Srinivas Samavedam
Independent Director
1.3 lacs
P Venkata Subbarao
Independent Director
3.95 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Material Consumed
164.4348
0%
Raw Material Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Ingredients and Intermediates
208.95
96.08%
Income from Services - Conversion Charges
4.39
2.02%
Other Operating Income - Export Incentives
4.14
1.90%
Pharmaceutical Ingredients and Intermediates
Pharmaceutical Ingredients and Intermediates
Income from Services - Conversion Charges
Income from Services - Conversion Charges
Other Operating Income - Export Incentives
Other Operating Income - Export Incentives
Stock DNARevenue and Profits:
Net Sales:
81 Cr
(Quarterly Results - Sep 2025)
Net Profit:
6 Cr
Pharmaceuticals & Biotechnology
INR 420 Cr (Micro Cap)
22.00
24
0.11%
0.33
9.06%
2.04
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
